Syndecan-1: A Novel Diagnostic and Therapeutic Target in Liver Diseases.

Zhang, Xiaoli; Zhao, Yalei; Liu, Liangru; He, Yingli

Zhang, Xiaoli; Zhao, Yalei; Liu, Liangru; He, Yingli.

Afiliação

Zhang X; Department of Infectious Diseases, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Zhao Y; National Regional Infectious Diseases Center Co-constructed by National Health Commission of PRC and People's Government of Shaanxi Province, Xi'an, China.
Liu L; Department of Infectious Diseases, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
He Y; National Regional Infectious Diseases Center Co-constructed by National Health Commission of PRC and People's Government of Shaanxi Province, Xi'an, China.

Curr Drug Targets ; 24(15): 1155-1165, 2023.

Article em En | MEDLINE | ID: mdl-37957867

Assuntos

Neoplasias Hepáticas; Sindecana-1; Humanos; Membrana Celular/metabolismo; Hepatócitos/metabolismo; Ligação Proteica; Sindecana-1/metabolismo

Palavras-chave

Heparan sulfate proteoglycans; Syndecan-1; hepatocytes; hepatocytes.; liver diseases; myofibroblasts

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sindecana-1 / Neoplasias Hepáticas Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google